Frequently Asked Questions
North America dominates the smoking cessation and nicotine de-addiction market due to the established healthcare infrastructure and high disposable income within the region.
The growth rate of the smoking cessation and nicotine de-addiction market is 15.4% in the forecast by 2028.
Major companies in the smoking cessation and nicotine de-addiction market are Cipla Inc., Johnson & Johnson Services, Inc., Takeda Consumer Healthcare Company Limited, Alkalon A/S, 22nd Century Group, Inc., GlaxoSmithKline plc., Imperial Brands, etc.
The rise in the number of people trying to quit smoking across the globe & government is emphasizing strict regulations to control nicotine and cigarette addiction due to its toxic effects on cardiac and respiratory systems, and high taxes on tobacco products are the growth drivers of the smoking cessation and nicotine de-addiction market.
Product type, type, and end-user are the factors on which the smoking cessation and nicotine de-addiction market research is based.
